Biotest
BIO.F
$81.84
Share price
0.48%
Change (1 day)
10.95%
Change (1 year)
Categories
Revenue for Biotest (BIO.F)
Revenue in 2024 (TTM): NZ$1.25 Billion
According to Biotest
's latest financial reports the company's current revenue (TTM 
) is NZ$1.37 Billion. In 2023 the company made a revenue of NZ$1.17 Billion an increase over the revenue in the year 2022 that were of NZ$0.85 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Biotest from 2009 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 (TTM) | NZ$1.25 B | 6.84% |
| 2023 | NZ$1.17 B | 36.55% |
| 2022 | NZ$0.85 B | -2.22% |
| 2021 | NZ$0.87 B | 12.59% |
| 2020 | NZ$0.77 B | 11.92% |
| 2019 | NZ$0.69 B | -0.65% |
| 2018 | NZ$0.70 B | 66.48% |
| 2017 | NZ$0.42 B | -48.53% |
| 2016 | NZ$0.81 B | -14.01% |
| 2015 | NZ$0.95 B | -1.33% |
| 2014 | NZ$0.96 B | 19.05% |
| 2013 | NZ$0.81 B | 16.38% |
| 2012 | NZ$0.69 B | -6.6% |
| 2011 | NZ$0.74 B | 16.18% |
| 2010 | NZ$0.64 B | -24.74% |
| 2009 | NZ$0.85 B |